Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Comparative bioavailability assessment between R107 tablet and 60 mg ketamine IV solution administered orally in healthy male and female participants under fasting conditions.


To see complete record on anzctr.org.au, please visit this link

Id: ACTRN12618001133224

Organisation Name: Zenith Technology Corporation Limited

Overal Status: Withdrawn

Start Date: 13/07/2018

Brief Summary: The objective of this study is to evaluate the comparative bioavailability of the test formulation relative to the that of a reference formulation, following oral administration of a single dose of R107 tablet or ketamine IV solution to healthy male and female subjects under fasting conditions.

Countries:
  • New Zealand
Conditions:
  • Depression
  • Anxiety


Total execution time in seconds: 0.17148113250732